{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:36:07Z","timestamp":1761755767856,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ajp.2019.08.016","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T19:16:57Z","timestamp":1567106217000},"page":"50-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["How to identify and manage non-response to clozapine?"],"prefix":"10.1016","volume":"45","author":[{"given":"Mujeeb U.","family":"Shad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Felzien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamalika","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simrat","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2019.08.016_bib0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.psy.49.2.176","article-title":"Clozapine toxicity in smoking cessation and with ciprofloxacin","volume":"49","author":"Brownlowe","year":"2008","journal-title":"Psychosomatics"},{"key":"10.1016\/j.ajp.2019.08.016_bib0010","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.clpt.2004.08.018","article-title":"Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism","volume":"76","author":"Granfors","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ajp.2019.08.016_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/01.pra.0000452561.98286.1e","article-title":"Prazosin in the treatment of PTSD","volume":"20","author":"Green","year":"2014","journal-title":"J. Psychiatr. Pract."},{"key":"10.1016\/j.ajp.2019.08.016_bib0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/0269881103017002014","article-title":"Serum clozapine levels: a review of their clinical utility","volume":"17","author":"Greenwood-Smith","year":"2003","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.08.016_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2019.08.016_bib0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.ajp.2019.08.016_bib0035","doi-asserted-by":"crossref","first-page":"e1133","DOI":"10.1097\/MJT.0000000000000501","article-title":"Clozapine for treatment-resistant schizophrenia","volume":"23","author":"Manu","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ajp.2019.08.016_bib0040","first-page":"1163","article-title":"Clinical pharmacology of atypical antipsychotics: an update","volume":"13","author":"Mauri","year":"2014","journal-title":"EXCLI J."},{"key":"10.1016\/j.ajp.2019.08.016_bib0045","article-title":"Ciprofloxacin and clozapine: a potentially fatal but underappreciated interaction","volume":"2016","author":"Meyer","year":"2016","journal-title":"Case Rep. Psychiatry"},{"key":"10.1016\/j.ajp.2019.08.016_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajp.2018.03.008","article-title":"Clozapine use in geriatric patients- Challenges","volume":"33","author":"Mukku","year":"2018","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.016_bib0055","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ajp.2019.07.028","article-title":"Ultra-treatment resistant schizophrenia- where do we stand?","volume":"44","author":"Naguy","year":"2019","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2019.08.016_bib0060","first-page":"17","article-title":"Genetic and clinical factors affecting plasma clozapine concentration","author":"Olsson","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.ajp.2019.08.016_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s002280000192","article-title":"Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia","volume":"56","author":"Raaska","year":"2000","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2019.08.016_bib0070","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00228-007-0313-5","article-title":"Interaction of clozapine and ciprofloxacin: a case report","volume":"63","author":"Sambhi","year":"2007","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2019.08.016_bib0075","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/17512433.2018.1478727","article-title":"A systematic review and combined analysis of therapeutic drug monitoring studies for oral paliperidone","volume":"11","author":"Schoretsanitis","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ajp.2019.08.016_bib0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S1092852913000850","article-title":"Role of alpha1 adrenergic antagonism in the mechanism of action of iloperidone: reducing extrapyramidal symptoms","volume":"18","author":"Stahl","year":"2013","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ajp.2019.08.016_bib0085","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/0269881118822171","article-title":"Clozapine augmentation strategies - a systematic meta-review of available evidence. Treatment options for clozapine resistance","volume":"33","author":"Wagner","year":"2019","journal-title":"J. Psychopharmacol."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819300334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201819300334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:33:39Z","timestamp":1761755619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201819300334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":17,"alternative-id":["S1876201819300334"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.08.016","relation":{},"ISSN":["1876-2018"],"issn-type":[{"type":"print","value":"1876-2018"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to identify and manage non-response to clozapine?","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}